The Financial Post reports in its Saturday edition that weed stocks headed for their worst week since the height of pandemic fears in March, 2020, as the glacial pace of national legalization efforts in the United States has investors doubting it will happen soon. The Post's Stefanie Marotta writes that the largest fund tracking the pot industry, the ETFMG Alternative Harvest ETF, is at its lowest price since November, 2020, and is down 60 per cent from its high on Feb. 10. Only three of the fund's 36 holdings are higher this week. Canopy Growth is down 19 per cent in the last five days, Cronos Group has sunk 21 per cent and Tilray has dropped 15 per cent. While the ETFMG ETF is dominated by Canadian cannabis companies, U.S. pot stocks are lagging as well. The Horizons U.S. Marijuana Index ETF (ticker HMUS) has dropped 12 per cent last week and 54 per cent since its 52-week high on Feb. 10. The global cannabis market's growth hinges on legalization in the U.S. However, that kind of regulatory change is unlikely to happen under the Biden administration, Barclays analysts wrote in a note to clients on Thursday. Canadian pot companies will struggle to compete with U.S. multistate operators, Barclays said.